Subscribe free

Newsletter

HPB & Spleen

Every new paper in this field, in your inbox.

FreeNo spamOne-click unsubscribe
HPB & Spleen9 Apr 2024

Embryologically Defined Peripancreatic Compartments

Researchers identified embryologically defined peripancreatic compartments and fusion planes, demonstrating distinct pancreatic compartments with potential significance in pancreatic cancer resection. Through manual preparation of body donors, they tracked mesogastria remnants and peripancreatic spaces sealed off from surrounding units. By following avascular embryologic fusion planes, they…

Am Surg9 Apr 2024

Prognostic Nomogram for Intrahepatic Cholangiocarcinoma

Researchers developed and validated a prognostic nomogram for intrahepatic cholangiocarcinoma, incorporating hepatitis C, CA19, tumor extent, tumor size, LVI, positive lymph nodes, and TMB as predictive factors. The nomogram demonstrated high accuracy in predicting patient outcomes with a c-index of 0.78 for the training set…

HPB (Oxford)9 Apr 2024

Limited Prognostic Impact of Preoperative TACE in Large HCC

Neoadjuvant transarterial chemoembolization (TACE) in upfront resectable large hepatocellular carcinoma (HCC) did not significantly impact long-term outcomes overall, but showed improved overall survival in HCC ≥10 cm and a trend in single HCC and after portal vein embolization/ligation. TACE should not be routinely performed in…

Ann Surg Oncol7 Apr 2024

Comparing Gemcitabine Plus Nab-Paclitaxel and Gemcitabine Plus S-1 as Neoadjuvant Chemotherapy in Pancreatic Cancer Patients

Patients with resectable/borderline-resectable pancreatic cancer underwent neoadjuvant chemotherapy with gemcitabine plus nab-paclitaxel or gemcitabine plus S-1. While there was no significant difference in 2-year progression-free survival rates between the two groups, the gemcitabine plus nab-paclitaxel regimen showed a longer median progression-free survival. Adverse events, completion…

J Gastrointest Surg7 Apr 2024

Development of a more individualized treatment approach for hepatic adenoma

Researchers reviewed the latest advancements in the diagnosis and management of hepatic adenomas. They classified it into 8 subtypes based on molecular pathology, each with unique characteristics and risks of malignant transformation. Larger adenomas over 5 cm have a higher risk of bleeding and malignancy…

J Gastrointest Surg5 Apr 2024

Impact of Preoperative Anemia on Outcomes in GEP-NET Resections

Patients with preoperative anemia undergoing curative-intent resection for gastroenteropancreatic neuroendocrine tumors (GEP-NETs) had higher rates of major complications and poorer long-term outcomes. Anemia was associated with worse overall survival, while postoperative transfusions were linked to lower overall survival and recurrence-free survival rates. Preoperative anemia affected…

J Gastrointest Surg5 Apr 2024

Transmesocolic reconstruction reduces delayed gastric emptying after pancreaticoduodenectomy.

Antecolic reconstruction after pancreaticoduodenectomy significantly increases the risk of delayed gastric emptying compared to transmesocolic reconstruction. Patients who underwent antecolic reconstruction had a higher incidence of severe delayed gastric emptying and a 2-fold increase in severe cases. Tmc reconstruction may be superior in minimizing the…